Young female doctor sitting at desk with stethoscope, ready for telehealth consultation.

Early Diagnosis in Dementia: Why it Matters More Than Ever

An early diagnosis of dementia is often delayed, not because people don’t believe in getting answers, but because the process can feel overwhelming. Families may notice changes for months or even years before seeking an evaluation. Fear, uncertainty, stigma, and the hope that symptoms will “just get better” all play a role. As a result, by the time a diagnosis is made, the person living with dementia may already be well into the disease process. In these later stages, crucial opportunities for planning, support, and early intervention have been missed.

In this article, I explore why early diagnosis matters, how it supports meaningful planning for families, and what new research is revealing about early changes in movement, communication, and brain health. These insights help caregivers understand what they’re seeing and support their loved one with greater clarity and confidence.

🌅 The Benefits of Early Diagnosis in Dementia

1. A Chance to Plan With, Not For 📝

One of the most meaningful benefits of early diagnosis is that it creates space for thoughtful, proactive planning while the person living with dementia can still meaningfully participate.

When families wait until symptoms are severe, decisions often happen in moments of crisis.

Early diagnosis allows for:

• intentional care planning
• legal and financial preparation
• home safety adjustments
• proactive caregiver support

But even more importantly, it protects the person’s ability to express their wishes, values, and preferences.

The early stage is a window, a period when the person can still articulate what matters most to them. Because of this, early diagnosis protects that window. It ensures that choices about care, living arrangements, finances, and personal preferences reflect the person’s own voice, not assumptions made later under stress.

In one study, older adults in the earlier stages of dementia were just as able as those without dementia to meaningfully answer questions about their values and quality of life priorities. This reinforces that people in the early stages can and should be included in conversations about what matters most to them.

Ultimately, early diagnosis isn’t just about identifying symptoms sooner. It’s about honoring the person’s identity, dignity, and agency while they can still meaningfully participate.

2. Understanding the Early Signs 🔍

Without a diagnosis, families often misinterpret behaviors:

• “They’re being difficult.”
• “They’re not trying hard enough.”
• “They’re doing this on purpose.”

A diagnosis reframes the behavior. It’s neurological, not intentional.

Movement Changes 🚶‍♂️

Studies show that subtle changes in gait and balance can appear early, sometimes even before memory symptoms. Researchers have found that slower gait, shorter steps, and reduced balance can all be early indicators of cognitive changes.

These physical shifts are linked to changes in the brain, not to stubbornness, laziness, or lack of effort. They help families understand that dementia affects far more than memory.

Language Changes 🗣️

Research also shows that early dementia can affect how someone retells stories, follows conversations, organizes their thoughts, and finds words.

In one study, a simple story‑retelling task identified mild cognitive impairment with over 90 percent sensitivity.

Together, these findings help families understand that repeating questions, losing the thread of a story, or struggling to find the right word are neurological changes, not personality changes.

What This Means for Families ❤️

When families understand these early signs, they can respond with less frustration, more compassion, and better support.

In turn, early diagnosis helps everyone interpret symptoms accurately and with empathy.

3. Access to Treatments, Clinical Trials, and Early Interventions 🌟

Many of the most promising Alzheimer’s treatments, including disease‑modifying therapies, work best in the earliest stages of the disease.

Early diagnosis opens the door to:

• clinical trials
• new medications
• non‑drug interventions
• lifestyle strategies that support brain health

Blood Biomarkers (Simplified) 🧪

Blood biomarkers like p‑tau217 are making early diagnosis more accessible. Research shows that elevated p‑tau217 levels strongly correlate with Alzheimer’s‑related brain changes. These tests are now FDA authorized for evaluating symptomatic Alzheimer’s disease.

While the science is complex, the takeaway is simple. We’re now able to identify Alzheimer’s earlier and more accurately than ever before.

Early Intervention Matters 💪

Early diagnosis also allows people to benefit from interventions that support both physical and cognitive health.

In one study, older adults with mild cognitive impairment who completed a home‑based exercise program experienced reduced fall risk, improved memory, and lower frailty.

Exercise isn’t just good for the body, it also supports the brain, and these benefits are strongest when started early.

🌱 Is It Better to Know Early? The Evidence Says Yes

Early diagnosis doesn’t take away hope. It creates it.

It gives families time, options, and clarity and gives the person living with dementia a voice. More doors to treatments, research, and support are open that simply aren’t available later on.

Thankfully, with new tools like blood biomarkers, gait analysis, language assessments, and early‑stage exercise interventions, we’re getting better at identifying changes long before they become overwhelming.

💬 Final Thoughts

Dementia is not just a medical condition. It’s a lived experience.

Early diagnosis doesn’t define a person, it equips them, and allows them the opportunity to walk this path with clarity and compassion.

If you or someone you love is noticing changes, even subtle ones, reaching out early is an act of strength, not fear.

Barnwal M, Baksh S, Ismail Z, Shade DM, Moghekar A, Ho SG, Rosenberg PB, Porsteinsson AP, Lyketsos CG; S‐CitAD Research Group. Blood biomarkers for Alzheimer’s disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation. Alzheimers Dement (N Y). 2026 Jan 18;12(1):e70203. doi: 10.1002/trc2.70203. PMID: 41560713; PMCID: PMC12812854.

Karel, M. J., Moye, J., Bank, A., & Azar, A. R. (2007). Three Methods of Assessing Values for Advance Care Planning: Comparing Persons With and Without Dementia: Comparing Persons With and Without Dementia. Journal of Aging and Health, 19(1), 123-151. https://doi.org/10.1177/0898264306296394 (Original work published 2007)

Mohajeri M, Bayles K, Alayiaboozar E, Salmani F, Yousefi F, Khatoonabadi AR. Evaluating the Validity of Story Retelling and Nonsense Phrase Repetition Tests for Diagnosing Mild Cognitive Impairment in Older Adults. Psychogeriatrics. 2026 Mar;26(2):e70130. doi: 10.1111/psyg.70130. PMID: 41549600.

Rice J, Falck RS, Seo YS, Dian L, Davis JC, Jehu DA, Parmar N, Madden K, Guy P, Roffey D, Liu-Ambrose T. Home-based exercise reduces fall risk in older adults with mild cognitive impairment who have sustained a hip fracture: A 6-month randomized controlled trial. Maturitas. 2026 Jan 12;206:108832. doi: 10.1016/j.maturitas.2026.108832. Epub ahead of print. PMID: 41548385.

Tolea MI, Rosenfeld A, Roy SV, Besser LM, O’Shea DM, Galvin JE. Gait, balance, and physical performance as markers of early Alzheimer’s disease and related dementia risk. J Alzheimers Dis. 2025 Nov;108(1_suppl):S185-S199. doi: 10.1177/13872877241313144. Epub 2025 Jan 26. PMID: 39865686; PMCID: PMC12301993.

Leave a Comment

Your email address will not be published. Required fields are marked *